Description: Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers active pharmaceutical ingredients (APIs), including antibiotics, anti-ulcer, anti-inflammatory/analgesic/anti-pyretic, anti-malarial, cardiac, anti-diabetic, anti-cold/anti-allergic, anti-diarrheal/anti-protozoal/anti-parasitic, anti-viral, anti-epileptic, anti-asthmatic, anti-fungal, anti-platelet agent, skeletal muscle relaxant, and anti-helmintic drugs, as well as excipients, topical steroids, corticosteroids, and enzymes. The company also provides formulation products, such as, laxative, anti-ulcer/enzyme, anti-asthmatic, anti-viral, anti-psychotic, vitamins, and other formulations. In addition, it offers veterinary pharmaceutical, nutraceutical, oncology, herbal, and surgical products. The company was founded in 1989 and is headquartered in Mumbai, India.
Home Page: www.vaishalipharma.com
706-709, Aravalli Business Center
Mumbai,
400092
India
Phone:
91 22 4217 1819
Officers
| Name | Title |
|---|---|
| Ms. Atul Arvind Vasani | Chairman & MD |
| Mr. Ratnesh Kumar Raghunath Singh | Chief Financial Officer |
| Ms. Vishwa Bipinbhai Mekhia | Company Sec. & Compliance Officer |
| Ms. Jagruti Atul Vasani | Whole Time Director |
| Mr. Dewansh Ajay Vasani | Exec. Director |
| Mr. Hemanth Damodar Pathak | Chief Exec. Officer |
| Ms. Priyanka Vasani | Chief Operating Officer |
Exchange: NSE
Country: IN : India
Currency: Indian Rupee (INR)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 30.5294 |
| Price-to-Book MRQ: | 5.1866 |
| Price-to-Sales TTM: | 2.2643 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 20 |